Clinical, Immunological and Virological Evolution in Patients with CD4 T-Cell Count above 500/mm3: Is there a Benefit to Treat with Highly Active Antiretroviral Therapy (HAART)?

Author： Piroth Lionel   Binquet Christine   Buisson Marielle   Kohli Evelyne   Duong Michel   Grappin Michèle   Abrahamowicz Michal   Quantin Catherine   Portier Henri   Chavanet Pascal  

Publisher： Springer Publishing Company

ISSN： 0393-2990

Source： European Journal of Epidemiology, Vol.19, Iss.6, 2004-06, pp. : 597-604

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Do Reduced Inpatient Costs Associated with Highly Active Antiretroviral Therapy (HAART) Balance the Overall Cost for HIV Treatment?

By Farnham Paul G.  

Applied Health Economics and Health Policy, Vol. 8, Iss. 2, 2010-03 ,pp. : 75-88

Adis International

Access to resources Recommend Favorite

Modifications of health resource-use in Italy after the introduction of highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV) infection. Pharmaco-economic implications in a population-based setting

By Torti C.   Casari S.   Palvarini L.   Quiros-Roldan E.   Moretti F.   Leone L.   Patroni A.   Castelli F.   Ripamonti D.   Tramarin A.   Carosi G.   the PEC Study Group  

Health Policy, Vol. 65, Iss. 3, 2003-09 ,pp. : 261-267

Elsevier

Access to resources Recommend Favorite

Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies: induction of a vaccine-specific CD4+ T-cell proliferative response in chronic hepatitis B carriers

By Jung M.-C.   Gruner N.   Zachoval R.   Schraut W.   Gerlach T.   Diepolder H.   Schirren C.-A.   Page M.   Bailey J.   Birtles E.   Whitehead E.   Trojan J.   Zeuzem S.   Pape G.R.  

Vaccine, Vol. 20, Iss. 29, 2002-10 ,pp. : 3598-3612

Elsevier

Access to resources Recommend Favorite

The critical role of CD4 + T-cell help in immunity to HIV

By Heeney J.L.  

Vaccine, Vol. 20, Iss. 15, 2002-05 ,pp. : 1961-1963

Elsevier

Access to resources Recommend Favorite

Effect of immunological adjuvant combinations on the antibody and T-cell response to vaccination with MUC1-KLH and GD3-KLH conjugates

By Kim  

Vaccine, Vol. 19, Iss. 4, 2000-10 ,pp. : 530-537

Elsevier

Access to resources Recommend Favorite